Caplyta 42 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3VA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,268
Award facts
- Contract value 100% obligated
- $21,267.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,267.55 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price, non-set-aside contract is performed from the contractor's Conshohocken, Pennsylvania location. CAPLYTA (lumateperone) is an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar depression, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which maintains a substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued up to $999,999,999.00 through December 31, 2031. This prime contract vehicle enables comprehensive global pharmaceutical support, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs worldwide. The non-competitive delivery order structure demonstrates AmerisourceBergen's established capability as a critical pharmaceutical distributor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FG3VA?
SPE2DR26FG3VA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FG3VA worth?
The government has obligated $21,268 on SPE2DR26FG3VA.
Is contract SPE2DR26FG3VA an order under another contract?
Yes. SPE2DR26FG3VA is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3VA competed?
The extent of competition for SPE2DR26FG3VA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award